Cns Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| IKARIAN CAPITAL, LLC | 08/14/2026 | 135.83 K | $649.27 K | 196.38% | 1.99% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 70.00 K | $334.60 K | 100.00% | 1.02% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 08/17/2026 | 41.57 K | $198.72 K | -31.85% | 0.61% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2026 | 13.52 K | $64.65 K | 0.00% | 0.20% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 10.23 K | $48.88 K | 100.00% | 0.15% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 6.99 K | $33.43 K | 100.00% | 0.10% |
| UBS GROUP AG | 08/13/2026 | 1.46 K | $6.98 K | 100.41% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 799 | $3.82 K | -39.01% | 0.01% |
| BARCLAYS PLC | 08/14/2026 | 19 | $91 | 100.00% | 0.00% |
| BARRETT & COMPANY, INC. | 07/24/2026 | 8 | $38 | 0.00% | 0.00% |
| DANSKE BANK A/S | 08/10/2026 | 1 | $5 | 0.00% | 0.00% |
| CITIGROUP INC | 08/03/2026 | 0 | $0 | -100.00% | 0.00% |
| MAI CAPITAL MANAGEMENT | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 0 | $0 | -100.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 08/05/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cns Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 17 institutional investors and hedge funds held shares of Cns Pharmaceuticals Inc. The most heavily invested institutionals were:
Ikarian Capital, LLC: 135,830
ADAR1 Capital Management, LLC: 70,000
Stonepine Capital Management, LLC: 41,573
BOOTHBAY FUND MANAGEMENT, LLC: 13,524
VANGUARD FIDUCIARY TRUST CO: 10,226
VANGUARD CAPITAL MANAGEMENT LLC: 6,993
4.10% of Cns Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 280.56 K shares in the last 24 months. This purchase volume represents approximately $852.91 K in transactions.